Cancer survival in Lithuania after the restoration of independence: Rapid improvements, but persisting major gaps

Acta Oncologica

Volumn 53, Issue 9, 2014, Pages 1238-1244

  Krilaviciute, Agne ^a   Smailyte, Giedre ^a   Brenner, Hermann ^b   Gondos, Adam ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER PROGNOSIS; CANCER SURVIVAL; COLORECTAL CANCER; ESOPHAGUS CANCER; GALLBLADDER CANCER; HEALTH CARE QUALITY; HODGKIN DISEASE; HUMAN; INDEPENDENCE; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LITHUANIA; LIVER CANCER; LONG TERM SURVIVAL; LUNG CANCER; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; POPULATION RESEARCH; PROSTATE CANCER; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; UTERUS CANCER; EARLY DIAGNOSIS; EPIDEMIOLOGY; FEMALE; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; REGISTER; STATISTICS AND NUMERICAL DATA; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LITHUANIA; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84907222987     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2014.888495     Document Type: Article

References (26)

1. Cancer incidence in five continents. Volume VIII. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. Lyon: IARC; 2002.
2. Gondos A, Bray F, Brewster DH, Coebergh JW, Hakulinen T, Janssen-Heijnen ML, et al. Recent trends in cancer survival across Europe between 2000 and 2004: A model-based period analysis from 12 cancer registries. Eur J Cancer 2008;44:1463-75.
3. Rosso S, Gondos A, Zanetti R, Bray F, Zakelj M, Zagar T, et al. Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: The role of screening and a comparison with data from the United States. Eur J Cancer 2010;46:3351-7.
4. van de Schans SA, Gondos A, van Spronsen DJ, Rachtan J, Holleczek B, Zanetti R, et al. Improving relative survival, but large remaining differences in survival for non-Hodgkin's lymphoma across Europe and the United States from 1990 to 2004. J Clin Oncol 2011;29:192-9.
5. Lithuanian 2011 population Census in Brief. Vilnius: Statistics Lithuania; 2012.
6. Statistics Lithuania. [cited June 2012]. Available from: http://www.stat.gov.lt/en.
7. Brenner H, Gefeller O, Hakulinen T. Period analysis for 'up-to-date' cancer survival data: Theory, empirical evaluation, computational realisation and applications. Eur J Cancer 2004;40:326-35.
8. Berrino F, Brown C, Moller T, Sobin L, Faivre J. ENCR recommendations: Condensed TNM for coding the extent of disease. European Network of Cancer Registries (ENCR), 2002.
9. Dickman PW. Estimating and modelling relative survival using Stata 2004 [cited 2013 June]. Available from: http://www.pauldickman.com/rsmodel/stata-colon/.
10. Brenner H, Hakulinen T. Up-to-date and precise estimates of cancer patient survival: Model-based period analysis. Am J Epidemiol 2006;164:689-96.
11. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307-16.
12. Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E, et al. Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol 2013; 24:2657-71.
13. Sandin S, Hjalgrim H, Glimelius B, Rostgaard K, Pukkala E, Askling J. Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: An epidemic that was. Cancer Epidemiol Biomarkers Prev 2006;15:1295-300.
14. Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 2002;94: 2015-23.
15. Gondos A, Bray F, Hakulinen T, Brenner H. Trends in cancer survival in 11 European populations from 1990 to 2009: A model-based analysis. Ann Oncol 2009;20:564-73.
16. Janssen-Heijnen ML, Gondos A, Bray F, Hakulinen T, Brewster DH, Brenner H, et al. Clinical relevance of conditional survival of cancer patients in Europe: Age-specific analyses of 13 cancers. J Clin Oncol 2010;28:2520-8.
17. Znaor A, Bray F. Thirty year trends in testicular cancer mortality in Europe: Gaps persist between the East and West. Acta Oncol 2012;51:956-8.
18. Brenner H, Francisci S, de Angelis R, Marcos-Gragera R, Verdecchia A, Gatta G, et al. Long-term survival expectations of cancer patients in Europe in 2000-2002. Eur J Cancer 2009;45:1028-41.
19. Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, et al. EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century. Ann Oncol 2003;14(Suppl 5):v128-49.
20. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, et al. Recent cancer survival in Europe: A 200002 period analysis of EUROCARE-4 data. Lancet Oncol 2007;8:784-96.
21. Verhoeven RH, Gondos A, Janssen-Heijnen ML, Saum KU, Brewster DH, Holleczek B, et al. Testicular cancer in Europe and the USA: Survival still rising among older patients. Ann Oncol 2013;24:508-13.
22. Maringe C, Walters S, Rachet B, Butler J, Fields T, Finan P, et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000-2007. Acta Oncol 2013;52:919-32.
23. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931-91.
24. Smailyte G, Aleknaviciene B. Incidence of prostate cancer in Lithuania after introduction of the Early Prostate Cancer Detection Programme. Public Health 2012;126:1075-7.
25. Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, et al. Lead time and overdiagnosis in prostate-specific antigen screening: Importance of methods and context. J Natl Cancer Inst 2009;101:374-83.
26. Lemmens VE, Bosscha K, van der Schelling G, Brennink-meijer S, Coebergh JW, de Hingh IH. Improving outcome for patients with pancreatic cancer through centralization. Br J Surg 2011;98:1455-62.